Physician profile
Ralph Rodriguez
NPI 1891990685
$7,293.95
in general payments reported to CMS, 2019-2025
54 companies · $1,251 in 2025
The $1,251 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,117 · 2020: $948 · 2021: $808 · 2022: $1,106 · 2023: $997 · 2024: $1,067 · 2025: $1,251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,315.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,320.48 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $883.26 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Janssen Pharmaceuticals, INC | $636.23 | 2019-2024 | Xarelto |
| Amgen INC. | $581.26 | 2019-2024 | Otezla, Repatha |
| Pfizer INC. | $367.23 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $361.32 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $314.35 | 2019-2025 | Jardiance, Mounjaro |
| Glaxosmithkline, LLC. | $308.01 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Amarin Pharma, INC. | $252.51 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $208.08 | 2019-2024 | |
| Abbott Laboratories | $157.96 | 2021-2024 | Freestyle Libre 2, Jot Dx, Freestyle Libre 3 |
| Novo Nordisk INC | $144.34 | 2020-2025 | Rybelsus, Ozempic |
| Exact Sciences Corporation | $144.13 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $140.08 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $116.37 | 2022-2025 | Zoryve, Livalo |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.